| Metabolic competition in the tumor microenvironment is a driver of cancer progression CH Chang, J Qiu, D O’Sullivan, MD Buck, T Noguchi, JD Curtis, Q Chen, ... Cell 162 (6), 1229-1241, 2015 | 2608 | 2015 |
| Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens Nature 515 (7528), 577-581, 2014 | 2097 | 2014 |
| New insights into cancer immunoediting and its three component phases—elimination, equilibrium and escape D Mittal, MM Gubin, RD Schreiber, MJ Smyth Current opinion in immunology 27, 16-25, 2014 | 1814 | 2014 |
| Tumor neoantigens: building a framework for personalized cancer immunotherapy MM Gubin, MN Artyomov, ER Mardis, RD Schreiber The Journal of clinical investigation 125 (9), 3413-3421, 2015 | 682 | 2015 |
| MHC-II neoantigens shape tumour immunity and response to immunotherapy E Alspach, DM Lussier, AP Miceli, I Kizhvatov, M DuPage, AM Luoma, ... Nature 574 (7780), 696-701, 2019 | 651 | 2019 |
| TREM2 modulation remodels the tumor myeloid landscape enhancing anti-PD-1 immunotherapy M Molgora, E Esaulova, W Vermi, J Hou, Y Chen, J Luo, S Brioschi, ... Cell 182 (4), 886-900. e17, 2020 | 354 | 2020 |
| High-dimensional analysis delineates myeloid and lymphoid compartment remodeling during successful immune-checkpoint cancer therapy MM Gubin, E Esaulova, JP Ward, ON Malkova, D Runci, P Wong, ... Cell 175 (4), 1014-1030. e19, 2018 | 354 | 2018 |
| Temporally distinct PD-L1 expression by tumor and host cells contributes to immune escape T Noguchi, JP Ward, MM Gubin, CD Arthur, SH Lee, J Hundal, MJ Selby, ... Cancer immunology research 5 (2), 106-117, 2017 | 280 | 2017 |
| The role of neoantigens in naturally occurring and therapeutically induced immune responses to cancer JP Ward, MM Gubin, RD Schreiber Advances in immunology 130, 25-74, 2016 | 229 | 2016 |
| Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells M Fehlings, Y Simoni, HL Penny, E Becht, CY Loh, MM Gubin, JP Ward, ... Nature communications 8 (1), 562, 2017 | 129 | 2017 |
| The odds of immunotherapy success MM Gubin, RD Schreiber Science 350 (6257), 158-159, 2015 | 112 | 2015 |
| Posttranscriptional gene regulation of IL-17 by the RNA-binding protein HuR is required for initiation of experimental autoimmune encephalomyelitis J Chen, J Cascio, JD Magee, P Techasintana, MM Gubin, GM Dahm, ... The Journal of Immunology 191 (11), 5441-5450, 2013 | 83 | 2013 |
| Overexpression of the RNA binding protein HuR impairs tumor growth in triple negative breast cancer associated with deficient angiogenesis MM Gubin, R Calaluce, JW Davis, JD Magee, CS Strouse, DP Shaw, L Ma, ... Cell Cycle 9 (16), 3357-3366, 2010 | 75 | 2010 |
| The RNA binding protein HuR differentially regulates unique subsets of mRNAs in estrogen receptor negative and estrogen receptor positive breast cancer R Calaluce, MM Gubin, JW Davis, JD Magee, J Chen, Y Kuwano, ... Bmc Cancer 10, 1-15, 2010 | 65 | 2010 |
| ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer RCE Hsieh, S Krishnan, RC Wu, AR Boda, A Liu, M Winkler, WH Hsu, ... Science immunology 7 (72), eabl9330, 2022 | 62 | 2022 |
| Coordinate regulation of GATA-3 and Th2 cytokine gene expression by the RNA-binding protein HuR C Stellato, MM Gubin, JD Magee, X Fang, J Fan, DM Tartar, J Chen, ... The Journal of Immunology 187 (1), 441-449, 2011 | 55 | 2011 |
| Cancer Immunoediting in the Era of Immuno-oncology MM Gubin, MD Vesely Clinical Cancer Research 28 (18), 3917-3928, 2022 | 54 | 2022 |
| Incisional hernia recurrence through genomic profiling: a pilot study R Calaluce, JW Davis, SL Bachman, MM Gubin, JA Brown, JD Magee, ... Hernia 17, 193-202, 2013 | 41 | 2013 |
| Conditional Knockout of the RNA-Binding Protein HuR in CD4+ T Cells Reveals a Gene Dosage Effect on Cytokine Production MM Gubin, P Techasintana, JD Magee, GM Dahm, R Calaluce, ... Molecular Medicine 20, 93-108, 2014 | 35 | 2014 |
| CD5 expression by dendritic cells directs T cell immunity and sustains immunotherapy responses M He, K Roussak, F Ma, N Borcherding, V Garin, M White, C Schutt, ... Science 379 (6633), eabg2752, 2023 | 31 | 2023 |
Robert SchreiberWashington University School of MedicineVerified email at immunology.wustl.edu
